Actively Recruiting
Study to Assess Accuracy and Safety of a New Real-Time Continuous Glucose Monitor in Adults with Type 1 or Type 2 Diabetes
Led by Henan University of Science and Technology · Updated on 2026-05-29
82
Participants Needed
1
Research Sites
13 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the accuracy and safety of a new real-time continuous glucose monitoring CGM system in adult patients with type 1 diabetes mellitus. This study aims to compare glucose readings from the CGM system with venous plasma sample measurements taken by a reference method. At least 42 participants will take part in this interventional trial sponsored by Henan University of Science and Technology. Participants will wear two sensors of the GS3 CGM device consecutively for 14 days. The system will provide interstitial glucose readings which will be compared immediately after each venous blood draw from the forearm. Participants will attend four visits to the clinical study site, including an initial screening visit, to complete the trial procedures. During the study, researchers will monitor system performance and document any system-related safety issues over the 14-day sensor wear period. Participants will be assessed through venous blood sampling and CGM readings, and they must be able to read instructions and comply with study requirements. The trial will last for the sensor wear time plus the visits, with safety and accuracy as the main outcomes evaluated.
CONDITIONS
Brief Title
Evaluation of the Accuracy and Safety of A Novel Real-Time Continuous Glucose Monitoring System
Research Team
P
Peng Liu
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here